Amphastar Pharmaceuticals Inc. (AMPH)
Symbol Info
Listed Symbol AMPH
Name Amphastar Pharmaceuticals Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $294,666,000
Latest Fiscal EPS $-0.12
Price Info
21 Day Moving Average $20.2919
21 Day EMA $20.196780
50 Day Moving Average $20.9342
50 Day EMA $20.593010
200 Day EMA $20.652690
200 Day Moving Average 21.260800
52 Week High $25.43
52 Week Low $17.71
52 Week Change $8.925600
Alpha 0.008691
Beta 1.1659
Standard Deviation 0.108985
R2 0.135099
Periods 60
Share Information
10 Day Average Volume 151,146
20 Day Average Volume 205,388
30 Day Average Volume 247,912
50 Day Average Volume 230,844
Outstanding Shares 47,226,496
Float Shares 46,291,273
Percent Float 98.02%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 305
Institute Holdings Date 2019-09-30
Institute Bought Previous 3 Months 1,445,755
Institute Holdings Percent 78.200000
Institute Sold Previous 3 Months 2,410,522
Insider Holdings Date
Insider Bought Previous 3 Months -
Insider Holdings Percent -
Insider Sold Previous 3 Months -
Insiders Shares Owned 935,223
Price Change
7 Day Price Change $-0.0200005
7 Day Percent Change -0.10%
21 Day Price Change $-0.9599991
21 Day Percent Change -4.63%
30 Day Price Change $-2.3799992
30 Day Percent Change -10.74%
Month To Date Price Change $-0.06
Month To Date Percent -0.30%
90 Day Price Change $-0.24
90 Day Percent Change -1.20%
Quarter To Date $-0.059999
Quarter To Date Percent -0.30%
180 Day Price Change $-1.199999
180 Day Percent Change -5.72%
200 Day Price Change $-0.67
200 Day Percent Change -3.28%
Year To Date $-0.129999
Year To Date Percent -0.65%
Profile
Description Amphastar Pharmaceuticals Inc is a specialty pharmaceutical company engaged in developing, manufacturing, marketing and selling generic and proprietary injectable and inhalation products. The business activities are operated through two reportable segments namely finished pharmaceutical products and API products. The finished pharmaceutical products segment manufactures, markets and distributes enoxaparin, naloxone, lidocaine, as well as various other critical and non-critical care drugs. The API segment manufactures and distributes RHI API and porcine insulin API. Its products are used in hospitals or urgent care clinical settings. Geographically the business presence of the firm is seen in the United States and France of which the US accounts for the majority of revenue.
Details
Issue Type CS
Market Cap $933,667,826
Sec Type EQS
Auditor Ernst & Young LLP
Total Shares Outstanding 47,226,496
CEO Jack Yongfeng Zhang
Employees 2,078
Last Audit UQ
Classification
CIK 0001297184
Industry Drug Manufacturers
Sector Healthcare
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address 11570 6th Street
Rancho Cucamonga, CA 91730
Website http://www.amphastar.com
Facisimile
Telephone +1 909 980-9484
Email jasons@amphastar.com
Key Ratios
Profitability
EBIT Margin 18.80
EBITDA Margin 24.6
Pre-Tax Profit Margin -1.9
Profit Margin Cont 18.55
Gross Margin 39.30
Profit Margin TOT 18.55
Income Statements
Revenue $248,527,000
Revenue Per Share $5.2624
Revenue 3 Years $1.11
Revenue 5 Years $4.76
Valuation Measures
PE Ratio 18.00
Enterprise Value $880,517,415
Price To Sales 3.756806
Price To Free Cash 38.800000
PE High Last 5 Years -
Price To Book 2.3
Price To Cash Flow 12.6
PE Low Last 5 Years -
Price To Tangible Book 2.6
Financial Strength
Total Debt To Equity 0.2
Int Coverage 339.7
Current Ratio 2.8
Leverage Ratio 1.6
Quick Ratio 1.7
Long Term Debt To Capital 0.13
Assets
Receivables Turnover 5.6
Invoice Turnover 2.40
Assets Turnover 0.50
Management Effectiveness
Return Assets 10.16
Return On Equity 15.11
Return On Capital 12.72
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
AMPH
Amphastar ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.